Abenex Invests in Santis LAB

September 23, 2024

Abenex has completed a minority growth investment in Santis LAB, a Franco‑Swiss laboratory that develops and markets food supplements sold through a network of roughly 2,000 pharmacies. The founders and management will remain operational and are investing alongside Abenex to support Santis' expansion into adjacent markets and new geographies.

Buyers
Abenex
Targets
Santis LAB
Industry
Food & Beverage
Location
France
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.